ANTX Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-09-14S-80001880438-26-000002SEC →
2026-09-1140001193125-26-389545SEC →
2026-09-0840001193125-26-385511SEC →
2026-09-0440001193125-26-383697SEC →
2026-09-0240001193125-26-380595SEC →
2026-08-2730001193125-26-370943SEC →
2026-08-1940001193125-26-357225SEC →
2026-08-171440001972481-26-000263SEC →
2026-08-1440001193125-26-351801SEC →
2026-08-1110-Q0001193125-26-344569SEC →
2026-08-118-K0001193125-26-344549SEC →
2026-07-1040001193125-26-301167SEC →
2026-07-1040001193125-26-301166SEC →
2026-07-1040001193125-26-301165SEC →
2026-07-1040001193125-26-301092SEC →
2026-06-098-K0001193125-26-262264SEC →
2026-06-048-K0001193125-26-257430SEC →
2026-06-0240001193125-26-253622SEC →
2026-05-15SCHEDULE 13G/A0002073679-26-000066SEC →
2026-05-1110-Q0001193125-26-216755SEC →
2026-05-118-K0001193125-26-216752SEC →
2026-04-22ARS0001193125-26-170328SEC →
2026-04-22DEFA14A0001193125-26-170321SEC →
2026-04-22DEF 14A0001193125-26-170314SEC →
2026-04-20EFFECT9999999995-26-001256SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
AN2 Therapeutics (ANTX) — Filings